CARGO Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CARGO Therapeutics Inc
Access all reports
CARGO Therapeutics Inc. is a clinical-stage biotechnology company dedicated to advancing the next generation of chimeric antigen receptor (CAR) T-cell therapies aimed at cancer treatment. The company is focused on developing transformative CAR T-cell therapies with the mission of outsmarting cancer and delivering more cures for patients globally. By addressing the limitations of currently approved cell therapies, such as limited durability, safety concerns, and unreliable supply, CARGO Therapeutics is working on engineering CAR T-cells with genetic "cargo" designed to enhance the ability to recognize and kill cancer cells.The company is headquartered in San Carlos, California, and its shares are listed on the Nasdaq.
Key slides for CARGO Therapeutics Inc
Corporate Presentation
CARGO Therapeutics Inc
Corporate Presentation
CARGO Therapeutics Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
CRGX
Country
🇺🇸 United States